APA (7th ed.) Citation

Olawaiye, A. B., Kim, J., Bagameri, A., Bishop, E., Chudecka-Głaz, A., Devaux, A., . . . Lorusso, D. (2024). Clinical Trial Protocol for ROSELLA: A phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer. Journal of Gynecologic Oncology, 35(4), 1. https://doi.org/10.3802/jgo.2024.35.e111

Chicago Style (17th ed.) Citation

Olawaiye, Alexander B., et al. "Clinical Trial Protocol for ROSELLA: A Phase 3 Study of Relacorilant in Combination with Nab-paclitaxel Versus Nab-paclitaxel Monotherapy in Advanced Platinum-resistant Ovarian Cancer." Journal of Gynecologic Oncology 35, no. 4 (2024): 1. https://doi.org/10.3802/jgo.2024.35.e111.

MLA (9th ed.) Citation

Olawaiye, Alexander B., et al. "Clinical Trial Protocol for ROSELLA: A Phase 3 Study of Relacorilant in Combination with Nab-paclitaxel Versus Nab-paclitaxel Monotherapy in Advanced Platinum-resistant Ovarian Cancer." Journal of Gynecologic Oncology, vol. 35, no. 4, 2024, p. 1, https://doi.org/10.3802/jgo.2024.35.e111.